ClinicalTrials.Veeva

Menu

Safety of Cream Containing Sericin and Turmeric in Healthy Volunteers

C

Chulalongkorn University

Status

Not yet enrolling

Conditions

Safety Issues

Treatments

Other: cream containing 2.5% sericin and 2%turmeric
Other: cream base
Other: cream containing 5%sericin and 2%turmeric
Other: cream containing 10%sericin and 2%turmeric

Study type

Interventional

Funder types

Other

Identifiers

NCT05869357
EC22010-20

Details and patient eligibility

About

The object of this study was to evaluate safety of cream containing sericin and turmeric in healthy volunteers.

Full description

There are 106 healthy volunteers in this study. Upper left arm is divided into 2 parts (2x2 cm) which are A and B area. Upper right arm is divided into 2 parts (2x2 cm) which are C and D area. Four area (A, B, C, and D) are randomized to receive cream containing 2.5% sericin and 2%turmeric, cream containing 5%sericin and 2%turmeric, cream containing 10%sericin and 2%turmeric, and cream base (Control group). Samples are applied 2 times/day for 6 days (Induction phase). Then, the volunteers will stop applying samples for 7 to 10 days (Free period). After that, Samples are applied 2 times/day for 3 days (Challenge phase). Erythema, melanin, humidity, transepidermal water loss, skin adverse reaction, and satisfaction are evaluated.

Enrollment

106 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 to 60 years
  • No skin diseases
  • No allergy to sericin and turmeric
  • No immunocompromised disease or using steroid for 2 weeks before participated in this study
  • Willing to participate in this study

Exclusion criteria

  • Uncontrolled disease, cancer, and heart disease
  • Cannot follow the protocol
  • Pregnancy and lactation
  • Participated in other studies

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

106 participants in 4 patient groups

cream containing 2.5% sericin and 2%turmeric
Experimental group
Description:
cream containing 2.5% sericin and 2%turmeric
Treatment:
Other: cream containing 2.5% sericin and 2%turmeric
cream containing 5%sericin and 2%turmeric
Experimental group
Description:
cream containing 5% sericin and 2%turmeric
Treatment:
Other: cream containing 5%sericin and 2%turmeric
cream containing 10%sericin and 2%turmeric
Experimental group
Description:
cream containing 10% sericin and 2%turmeric
Treatment:
Other: cream containing 10%sericin and 2%turmeric
cream base
Experimental group
Description:
cream base without sericin and tumeric
Treatment:
Other: cream base

Trial contacts and locations

1

Loading...

Central trial contact

Pornanong Aramwit, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems